Evidence map›Paper›PMID 28585158›Full record

ArticleProbiotics and antimicrobial proteins2018

Properties of Probiotics Kocuria SM1 and Rhodococcus SM2 Isolated from Fish Guts.

S M Sharifuzzaman, Hafizur Rahman, Dawn A Austin, B Austin

Abstract read
PubMed Publisher
In one paragraph

Article in Probiotics and antimicrobial proteins, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Potential ofMicroorganisms · 2025
    Article
  3. Article
  4. Microorganisms · 2024
    Article
  5. Review
  6. Article
  7. Whole genome analysis of host-associatedFrontiers in microbiology · 2022
    Article
  8. The Gut Microbiota of Healthy andFrontiers in microbiology · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

S M SharifuzzamanInstitute of Marine Sciences and Fisheries, University of Chittagong, Chittagong, 4331, Bangladesh. sharifuzzaman@cu.ac.bd.
Hafizur RahmanSchool of Life Sciences, Heriot-Watt University, Edinburgh, Scotland, EH14 4AS, UK.
Dawn A AustinSchool of Life Sciences, Heriot-Watt University, Edinburgh, Scotland, EH14 4AS, UK.
B AustinSchool of Life Sciences, Heriot-Watt University, Edinburgh, Scotland, EH14 4AS, UK.
Heriot-Watt University · GBIndependent University · BDUniversity of Chittagong · BDUniversity of Stirling · GB

Funding

Heriot-Watt University PhD studentship
6 · The paper itself

Abstract

This study characterized probiotics Kocuria SM1 and Rhodococcus SM2, which were recovered from the intestinal microbiota of rainbow trout (Oncorhynchus mykiss, Walbaum). The cultures were Gram-positive, non-motile, catalase-positive and oxidase-negative cocci or rods. Cell multiplication of SM1 and SM2 was observed at 4-37 °C (45 °C for SM1), in 0-20% (w/v) NaCl and at pH 2-11. The viability was not affected when exposed to pepsin at pH 2.0 and 3.0, and pancreatin at pH 8.0. Neither isolates were chrome azurol S-positive for siderophore production. Of the 19 common enzymes analysed using the API-ZYM system, only 8 were evident in the culture of SM1 compared to 11 enzymes for SM2. The secondary metabolites of both probiotics were inhibitory to Acinetobacter baumannii, Vibrio anguillarum and V. ordalii; SM2 inhibited Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Staphylococcus aureus. SM2 was resistant to penicillin and sulphatriad, out of six antimicrobial agents; SM1 was resistant to sulphatriad. These results suggest that Kocuria SM1 and Rhodococcus SM2 are able to grow over a wide range of temperature, salinity and pH, including in conditions that mimic the gastrointestinal environment of fish and produce extracellular enzymes that may have a role in the host digestive processes. Importantly, Rhodococcus SM2 displays a high degree of bacteriocinogenic potential against multi-drug-resistant human pathogens that have never been documented among the gut microbiota of fish.

Indexed as

AnimalsAnti-Bacterial AgentsAntibiosisGastrointestinal MicrobiomeIntestinesOncorhynchus mykissProbioticsRhodococcusAnti-Bacterial AgentsAntagonismAntibiogrammeIdentificationIntestinal microbiotaProbioticsRainbow trout

Identifiers

PMID28585158
OpenAlexW2622540939

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.